{"id":"NCT00608985","sponsor":"Midnight Pharma, LLC","briefTitle":"Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia","officialTitle":"Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group Polysomnography Study to Assess the Efficacy and Safety of a 16-day Oral Administration of ACT-078573 in Adult Subjects With Chronic Primary Insomnia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03","primaryCompletion":"2009-09","completion":"2009-11","firstPosted":"2008-02-06","resultsPosted":"2013-02-07","lastUpdate":"2016-03-14"},"enrollment":709,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Primary Insomnia"],"interventions":[{"type":"DRUG","name":"almorexant","otherNames":[]},{"type":"DRUG","name":"almorexant","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"zolpidem","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"PLACEBO_COMPARATOR"},{"label":"4","type":"ACTIVE_COMPARATOR"}],"summary":"A polysomnography study to evaluate the effect, safety and tolerability of oral administration of almorexant (ACT 078573) in adult subjects with primary insomnia.","primaryOutcome":{"measure":"Change From Baseline to Day 1&2 in Wake After Sleep Onset (WASO)","timeFrame":"From baseline to Day 1&2","effectByArm":[{"arm":"Placebo","deltaMin":85,"sd":39.81},{"arm":"Almorexant 100mg","deltaMin":86.6,"sd":39.17},{"arm":"Almorexant 200mg","deltaMin":92.3,"sd":35.92},{"arm":"Zolpidem 10mg","deltaMin":76.5,"sd":36.95}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG003","p":"0.0376"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":5},"locations":{"siteCount":91,"countries":["Australia","Austria","Belgium","Bulgaria","Czechia","Denmark","Finland","France","Germany","Hungary","Israel","Italy","Poland","Slovakia","South Africa","Spain","Sweden","Switzerland","Ukraine","United Kingdom"]},"refs":{"pmids":["28735928"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":177},"commonTop":["HEADACHE","DIZZINESS","FATIGUE","NAUSEA","SOMNOLENCE"]}}